American International Group Inc vs Canopy Growth Corp — how do they compare? American International Group Inc trades at $76.37 (market cap $40.42B), while Canopy Growth Corp trades at $1.03 (market cap $421.10M). The key difference: American International Group Inc is far larger — about 96× Canopy Growth Corp's market cap, and American International Group Inc pays a 2.59% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| AIG | CGC | |
|---|---|---|
Market Cap | $40.42B | $421.10M |
Sector | Financials | Health |
52-Week High | $86.59 | $1.92 |
52-Week Low | $71.89 | $0.86 |
Enterprise Value | $48.06B | $378.55M |
Dividend Yield | 2.59% | — |
Signals from Pluang's Aura AI — not financial advice
AIG trades at $77.61, down 1.49% today, with a bearish technical signal but strong fundamental performance. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.00 exceeding the $1.92 estimate. The company maintains solid profitability with an 11.12% net income margin and a P/E of 14.11, indicating reasonable valuation. Cash flow from operations remains positive at $3.31 billion for 2025, supporting dividend payments of $0.50 per share.
The outlook is mixed; analyst consensus is a Buy with a $89.00 price target, suggesting 14.7% upside, but technical indicators signal near-term caution. Risks include competitive pricing pressure and geopolitical exposures, while opportunities lie in disciplined underwriting and AI integration. Investor sentiment is cautiously optimistic amid steady premium growth and expense control.
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Trailing returns across standard periods
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →